Hemington Wealth Management Artivion, Inc. Transaction History
Hemington Wealth Management
- $645 Million
- Q1 2025
A detailed history of Hemington Wealth Management transactions in Artivion, Inc. stock. As of the latest transaction made, Hemington Wealth Management holds 9 shares of AORT stock, worth $265. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9
Previous 9
-0.0%
Holding current value
$265
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding AORT
# of Institutions
187Shares Held
38.7MCall Options Held
19.5KPut Options Held
2.5K-
Black Rock Inc. New York, NY6.64MShares$196 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C32.9MShares$85.7 Million0.09% of portfolio
-
Perceptive Advisors LLC New York, NY2.79MShares$82.4 Million2.87% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.78MShares$82.1 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.26MShares$66.7 Million0.0% of portfolio
About ARTIVION, INC.
- Ticker AORT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 40,316,100
- Market Cap $1.19B
- Description
- Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial...